Literature DB >> 18957419

Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Emily A Oestreich1, Sundeep Malik, Sanjeewa A Goonasekera, Burns C Blaxall, Grant G Kelley, Robert T Dirksen, Alan V Smrcka.   

Abstract

Recently, we identified a novel signaling pathway involving Epac, Rap, and phospholipase C (PLC)epsilon that plays a critical role in maximal beta-adrenergic receptor (betaAR) stimulation of Ca2+-induced Ca2+ release (CICR) in cardiac myocytes. Here we demonstrate that PLCepsilon phosphatidylinositol 4,5-bisphosphate hydrolytic activity and PLCepsilon-stimulated Rap1 GEF activity are both required for PLCepsilon-mediated enhancement of sarcoplasmic reticulum Ca2+ release and that PLCepsilon significantly enhances Rap activation in response to betaAR stimulation in the heart. Downstream of PLCepsilon hydrolytic activity, pharmacological inhibition of PKC significantly inhibited both betaAR- and Epac-stimulated increases in CICR in PLCepsilon+/+ myocytes but had no effect in PLCepsilon-/- myocytes. betaAR and Epac activation caused membrane translocation of PKCepsilon in PLCepsilon+/+ but not PLCepsilon-/- myocytes and small interfering RNA-mediated PKCepsilon knockdown significantly inhibited both betaAR and Epac-mediated CICR enhancement. Further downstream, the Ca2+/calmodulin-dependent protein kinase II (CamKII) inhibitor, KN93, inhibited betaAR- and Epac-mediated CICR in PLCepsilon+/+ but not PLCepsilon-/- myocytes. Epac activation increased CamKII Thr286 phosphorylation and enhanced phosphorylation at CamKII phosphorylation sites on the ryanodine receptor (RyR2) (Ser2815) and phospholamban (Thr17) in a PKC-dependent manner. Perforated patch clamp experiments revealed that basal and betaAR-stimulated peak L-type current density are similar in PLCepsilon+/+ and PLCepsilon-/- myocytes suggesting that control of sarcoplasmic reticulum Ca2+ release, rather than Ca2+ influx through L-type Ca2+ channels, is the target of regulation of a novel signal transduction pathway involving sequential activation of Epac, PLCepsilon, PKCepsilon, and CamKII downstream of betaAR activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957419      PMCID: PMC2615515          DOI: 10.1074/jbc.M806994200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 2.  Cardiac excitation-contraction coupling.

Authors:  Donald M Bers
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling.

Authors:  T G Jin; T Satoh; Y Liao; C Song; X Gao; K Kariya ; C D Hu; T Kataoka
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

4.  Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart.

Authors:  Susan Currie; Christopher M Loughrey; Margaret-Anne Craig; Godfrey L Smith
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

5.  Activation of phospholipase C-epsilon by heterotrimeric G protein betagamma-subunits.

Authors:  M R Wing; D Houston; G G Kelley; C J Der; D P Siderovski; T K Harden
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

6.  Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel.

Authors:  Jin O-Uchi; Hiroyuki Sasaki; Satoshi Morimoto; Yoichiro Kusakari; Hitomi Shinji; Toru Obata; Kenichi Hongo; Kimiaki Komukai; Satoshi Kurihara
Journal:  Circ Res       Date:  2008-05-08       Impact factor: 17.367

7.  A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase.

Authors:  M Schmidt; S Evellin; P A Weernink; F von Dorp; H Rehmann; J W Lomasney; K H Jakobs
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

8.  Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins.

Authors:  Grant G Kelley; Sarah E Reks; Alan V Smrcka
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

9.  Epac: a new cAMP target and new avenues in cAMP research.

Authors:  Johannes L Bos
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

10.  Direct activation of phospholipase C-epsilon by Rho.

Authors:  Michele R Wing; Jason T Snyder; John Sondek; T Kendall Harden
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

View more
  97 in total

Review 1.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

Review 2.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

3.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 4.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

Review 5.  Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.

Authors:  Colin A Leech; Oleg G Chepurny; George G Holz
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

6.  Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.

Authors:  Wagner Santos Coelho; Mauro Sola-Penna
Journal:  Mol Cell Biochem       Date:  2012-09-26       Impact factor: 3.396

7.  Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.

Authors:  Igor Dzhura; Oleg G Chepurny; Grant G Kelley; Colin A Leech; Michael W Roe; Elvira Dzhura; Parisa Afshari; Sundeep Malik; Michael J Rindler; Xin Xu; Youming Lu; Alan V Smrcka; George G Holz
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

8.  A CaMKII/PDE4D negative feedback regulates cAMP signaling.

Authors:  Delphine Mika; Wito Richter; Marco Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.

Authors:  Wenli Yang; Fang C Mei; Xiaodong Cheng
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

10.  Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.

Authors:  Nataliya Dybkova; Stefan Wagner; Johannes Backs; Thomas J Hund; Peter J Mohler; Thomas Sowa; Viacheslav O Nikolaev; Lars S Maier
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.